Cryopreserved Amniotic Membrane, Autologous Serum Eye Drops, and Tea-Tree Oil Lid Scrubs in combination for the treatment of Keratoconjunctivitis in a Staphylococcus Hypersensitive Teenager
Main Article Content
Abstract
Abstract
Background and Objective:
The purpose is to present an interventional case report detailing recurrent bilateral keratoconjunctivitis secondary to Staphylococcus hypersensitivity in a teenage female. At least three times yearly, for five years, the patient has experienced episodes of severe bilateral catarrhal infiltrative or phlyctenular keratoconjunctivitis. Comprehensive corneal and conjunctival cultures had been historically performed, twice, yielding only growth of Staphylococcus aureus and epidermidis. Prior short-term treatment regimens of topical steroids and antibiotics had not prevented recurrences.
Methods:
This is an interventional case report: In this patient, placement of a topical cryopreserved amniotic membrane, Prokera Slim (PKS by BioTissue), after one week of topical steroid treatment (Durezol (difluroprednate 0.05%) qid) in the right eye (OD) is compared to a steroid (difluroprednate 0.05%) taper in the left eye (OS) over an approximate one-month time period. Both eyes then continue chronic, long-term maintenance therapy with autologous serum eye drops (ASED) dosed six times daily and tea tree oil containing lids scrubs (SteriLid Foam by TheraTears) two times daily, until the present time. Supportive meibomian gland expression for meibomian gland dysfunction was also performed at the three month treatment mark.
Results:
The PKS treatment in the right eye resulted in superior visual acuity and ocular comfort when compared to a steroid taper in the left eye over an approximate one-month time period. These results were maintained in the left eye at the 12 month- time frame. The right eye experienced a recurrence when the patient self-discontinued all therapy in both eyes at the 4 month mark. With re-initiation of maintenance therapy of ASED and tea tree oil containing lids scrubs, she has remained symptom-free for over eight months in the right eye.
Conclusions:
Further comparison and study of the treatment modalities above could result in a potentially faster, safer, and superior treatment and prevention protocol for topical ocular inflammation in Staphylococcus hypersensitive keratoconjunctivitis, particularly in pediatric populations.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.
References
2. Lee, S. H., Oh, D. H., Jung, J. Y., Kim, J. C., & Jeon, C. O. (2012 Aug 15). Comparative ocular microbial communities in humans with and without blepharitis. Invest Ophthalmol Vis Sci, 53(9), 5585-5593.
3. Wong, Victoria W Y MMedSc, MRCS, Lai, Timothy Y Y MD, FRCS, Chi, Stanley C C FRCS, & Lam, Dennis S C MD, FRCOphth. (2011). Pediatric ocular surface infections: A 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea, 30(9), 995-1002
4. Jayamanne, D. G., Dayan, M., Jenkins, D., & et al. (1997). The role of staphylococcal superantigens in the pathogenesis of marginal keratitis. Eye, 11, 618—621
5. Tetz, M. R., & Klein U, V. H. (1997). Staphylococcus-associated blepharokeratoconjunctivitis. Clinical findings, pathogenesis and therapy. Ophthalmologe, 94(3), 186--190.
6. Ueta, M., Sotozono, C., Takahashi, J., Kojima, K., & Ueta, M. (Aug 2009). Examination of staphylococcus aureus on the ocular surface of patients with catarrhal ulcers. Cornea, 28(7), 780--782.
7. Thygeson, P. (1969). Complications of staphylococcic blepharitis doi:http://dx.doi.org/10.1016/0002-9394(69)90711-9.
8. Ficker, L., Seal, D., & Wright, P. (1989). Staphylococcal infection and the limbus: Study of the cell-mediated immune response. Eye, 3, 190--193.
9. Hussein, N., & Schwab, I. R. (2013). Chapter 22: blepharitis and inflammation of the eyelids. In W. Tasman, & E. A. Jaeger (Eds.), Duane's ophthalmology (12th Edition ed., pp. Volume 4). 530 Walnut Street, Philadelphia, PA 19106 USA: Lippincott Williams & Wilkins.
10. Bierdeman, M., Torres, A. M., Caballero, A. R., Tang, A., & O'Callaghan, R. J. (2017). Reactions with antisera and pathological effects of staphylococcus aureus gamma-toxin in the cornea. Curr Eye Res, Mar 27:1-8(10.1080/02713683.2017.1279636.)
11. Seal, D., Ficker, L., Ramakrishnan, M., & et al. (1990). Role of staphylococcal toxin production in blepharitis. . Ophthalmology, 97(12), 1684-–1688.
12. Abraham, S. (2015 Oct). Corneal complications of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol., 15(5), 489-494.
13. K?l?ç Müftüo?lu, ?., & Ayd?n Akova, Y. (2016). Clinical findings, follow-up and treatment results in patients with ocular rosacea. Turkish Journal of Ophthalmology, 46(1), 1-6.
14. López-Valverde, G., Garcia-Martin, E., Larrosa-Povés, J. M., Polo-Llorens, V., & Pablo-Júlvez, L. E. (2016 May). Therapeutical management for ocular rosacea. Case Rep Ophthalmol., 7(1), 237-242.
15. Gao, Y., Di Pascuale, M., Li, W.; et al. High prevalence of ocular Demodex in lashes with cylindrical dandruffs. Invest Ophthalmol Vis Sci 2005; 46:3089–3094.
16. Kheirkhah, A., Casas, V., Li, W., Raju, V. K., & Tseng, S. C. (2007 May). Corneal manifestations of ocular demodex infestation. Am J Ophthalmol, 143(5), 743-749.
17. Suzuki, T., Mitsuishi, Y., Sano, Y., Yokoi, N., & Kinoshita, S. (2005). Phlyctenular keratitis associated with meibomitis in young patients. American Journal of Ophthalmology, 140(1), 77.e1-77.e7.
18. Blackie, C.A.; Solomon, J.D.; Scaffidi, R.C.; et al. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009 Aug; 28(7):789-94.
19. Carnahan, M. C., & Goldstein, D. A. (2000). Ocular complications of topical, peri-ocular, and systemic corticosteroids. Current Opinion in Ophthalmology, 11(6), 478-483.
20. Daniel, B. S., & Orchard, D. (2015 Aug). Ocular side-effects of topical corticosteroids: What a dermatologist needs to know Australas J Dermatol, 56(3), 164-169.
21. Kwok, A., Lam, D., Ng, J., & et al. (1997). Ocular-hypertensive response to topical steroids in children. Ophthalmology, 104(12), 2112-2116.
22. Renfro, L., & Snow, J. S. (1992 Jul). Ocular effects of topical and systemic steroids. Dermatol Clin, 10(3), 505-512.
23. Zhang, S., Zhu, Y. T., Chen, S. Y., & et al. (2014). Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex. J Biol Chem, 289, 13531-13542.
24. Tabatabaei, S. A., Soleimani, M., Behrouz, M. J., Torkashvand, A., Anvari, P., & Yaseri, M. (2017 Apr). A randomized clinical trial to evaluate the usefulness of amniotic membrane transplantation in bacterial keratitis healing. Ocul Surf., 15(2), 218-226.
25. Cheng, A. M., Zhao, D., Chen, R., Yin, H. Y., Tighe, S., Sheha, H., et al. (2016 Jan). Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf., 14(1), 56-63.
26. Yang, J.; Yang, F.; Peng, C.; et al. (2013). Surgical treatment of 32 cases of long-term atopic keratoconjunctivitis using the amniotic membrane. Eye, 27(11), 1254-1262.
27. Sheha, H., Liang, L., Li, J., & Tseng, S. C. (2009 Dec). Sutureless amniotic membrane transplantation for severe bacterial keratitis. Cornea, 28(10), 1118--1123.
28. Thomsen, N. A., Hammer, K. A., Riley, T. V., Van Belkum, A., & Carson, C. F. (2013 Apr). Effect of habituation to tea tree (melaleuca alternifolia) oil on the subsequent susceptibility of staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol. Int J Antimicrob Agents, 4(41), 343--351.
29. Hammer, K. A., Carson, C. F., & Riley, T. V. (2012). Effects of melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multistep antibiotic resistance and antimicrobial susceptibility. . Antimicrobial Agents and Chemotherapy, 56(2), 909--915.
30. Cox, S. D., Mann, C. M., Markham, J. L., Bell, H. C., Gustafson, J. E., Warmington, J. R., et al. (2000 Jan). The mode of antimicrobial action of the essential oil of melaleuca alternifolia (tea tree oil).. J Appl Microbiol., 88(1), 170--175.
31. Koo, H., Kim, T. H., Kim, K. W., Wee, S. W., Chun, Y. S., & Kim, J. C. (2012). Ocular surface discomfort and demodex: Effect of tea tree oil eyelid scrub in demodex Blepharitis. Journal of Korean Medical Science, 27(12), 1574-–1579.
32. Burstein, N. L. (1985). The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc U K., 104(Pt 4), 402-409.
33. Oum, B. S., Kim, N. M., Lee, J. S., & et al. (2014). Effects of fluoroquinolone eye solutions without preservatives on human corneal epithelial cells in vitro. Ophthalmic Res, 51, 216-223.
34. Homeyer, D., Sanchez, C. j., Mende, K., & et al. (2015 Apr). In vitro activity of melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells. Medical Mycology, 53(3), 285-294.
35. Azari, A. A., & Rapuano, C. J. (2015 May). Autologous serum eye drops for the treatment of ocular surface disease. Eye Contact Lens, 41(3), 133-140.
36. Jeng, B. H., & Dupps, W. J. J. (2009 Dec). Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea, 28(10), 1104-1108.
37. Cho, Y. K., Huang, W., Kim, G. Y., & Lim, B. S. (2013 Jan). Comparison of autologous serum eye drops with different diluents. Curr Eye Res, 38(1), 9-17.
38. Semeraro, F., Forbice, E., Braga, O., Bova, A., Di Salvatore, A., & Azzolini, C. (2014). Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. . BioMed Research International, 826970, 2017 Jul 31.
39. Fischer, K. R., Opitz, A., Böeck, M., & Geerling, G. (2012 Nov). Stability of serum eye drops after storage of 6 months. Cornea, 31(11), 1313-1318.
40. Kojima, T., Higuchi, A., Goto, E., Matsumoto, Y., Dogru, M., & Tsubota, K. (2008 Sep). Autologous serum eye drops for the treatment of dry eye diseases. Cornea, 27(Suppl 1), S25-S30.
41. Bron, A. J., De Paiva, C. S., Chauhan SK, & et al. (2017). TFOS DEWS II pathophysiology report. Ocul Surf., 15(3), 438-510.